| PEB0088 | The feasibility and challenges of diagnosing and treating acute HIV infection in a resource limited high HIV incidence setting in Eswatini | E-poster | B1 |
| PEB0089 | Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in acute and early human immunodeficiency virus (HIV)'1 infection: A DIAMOND subgroup analysis | E-poster | B1 |
| PEB0090 | Evaluation of viral suppression one year after genotyping test to guide salvage therapy among adult patients infected with HIV-1 B or HIV-1 F subtype at polymerase region | E-poster | B2 |
| PEB0091 | Trends in clinical follow-up between 2008-2018 among people living with HIV in the TREAT Asia and Australian HIV Observational Databases (TAHOD and AHOD) | E-poster | B3 |
| PEB0092 | Causes and incidence of hospitalization in patients enrolled in the ICONA cohort | E-poster | B3 |
| PEB0093 | A comparison of mortality in patients with aggressive AIDS-related lymphoma treated with and without rituximab | E-poster | B3 |
| PEB0094 | Evaluation of low level viremia in a multinational study and associations with clinical outcomes, immunologic outcomes and micronutrients | E-poster | B3 |
| PEB0095 | Time to ART Initiation from HIV diagnosis and survival to fatal and non-fatal severe events: An analysis of the HIV Atlanta Veterans Affairs Cohort Study, 2005-2019 | E-poster | B3 |
| PEB0096 | Risk of hospitalisation according to demographic, socioeconomic, mental health and lifestyle factors and causes for admission in people living with HIV in the UK | E-poster | B3 |
| PEB0097 | Cohort study on HIV/AIDS-related mortality for key populations managed under programmatic conditions in Papua New Guinea: 2008 - 2019 | E-poster | B3 |